摘要
目的探讨经肝动脉化疗栓塞（TACE）联合超声引导下射频消融（RFA）治疗原发性肝癌的疗效。方法对2013年1月至2014年5月行TACE联合RFA治疗的81例中晚期原发性肝癌病人资料进行回顾性分析，并与同期单独行TACE的99例中晚期原发性肝癌病人进行疗效比较。结果TACE联合RFA治疗的中晚期原发性肝癌病人疗效明显好于单纯行TACE组病人，TACE联合RFA组在肿瘤的疾病控制率（93．8％）、完全缓解率（13．6％）及部分缓解率（44．4%）均优于单纯行TACE组（76．8％、5．1％、30．3％），P〈0．05；AFP下降水平也优于单纯行TACE组（P〈0．05）。结论TACE联合RFA治疗中晚期原发性肝癌疗效好，可做临床推广。
Objective To explore the efficacies of transcatheter hepatic arterial chemoembolization （TACE） plus ultrasound-guided radioffequency ablation （RFA） in the treatment of advanced hep- atocellular carcinoma （HCC）. Methods From January 2013 to May 2014, 81 patients with advanced HCC underwent TACE plus ultrasound-guided RFA. And their efficacies were compared with 99 counterparts with advanced HCC undergoing TACE alone. The clinical data of these patients were an- alyzed retrospectively. Results Compared to TACE alone , TACE plus RFA demonstrated statistically significant benefits in disease control rate, complete remission rate, partial remission rate and a de- cline of alpha fetal protein （AFP）. Conclusions Compared to TACE alone, TACE plus RFA offers better theraoeutic efficacies for advanced HCC.
出处
《腹部外科》
2015年第1期57-59,共3页
Journal of Abdominal Surgery
关键词
肝肿瘤
导管消融术
经肝动脉化疗栓塞
Liver neoplasms
Catheter ablation
Transcatheter hepatic arterial chemoembolization
